Research Interest: Virology
Name | PhD Program | Research Interest | Publications |
---|---|---|
Schrank, Travis PUBLICATIONS |
PHD PROGRAM RESEARCH INTEREST |
I am a surgeon-scientist specialized in head and neck cancers. My goal is to address translationalquestions with genomic data and bioinformatic methods, as well as benchtop experimentation. My clinical practice as a head and neck cancer surgeon also influences my research by helping me seek solutions to problems that will directly inform gaps in the current treatment protocols. I have developed a strong interest in HPV genomics as well as HPV/host genome integrations, as these factors are intrinsically related to transcriptional diversity and patient outcomes in HPV-associated head and neck cancers. Our work has helped to demonstrate that a novel mechanism of HPV-mediated oncogenesis requiring NF-kB activation is present in nearly 50% of oropharyngeal tumors. In this vein, we are aggressively investigating the cellular interplay between the NF-kB pathway and persistent HPV infection, tumor radiation response, NRF2 signaling, and more. Another outgrowth of this work has been investigating APOBEC3B and its non-canonical roles in regulating transcription. Our preliminary work has demonstrated that APOBEC3B has surprisingly strong transcriptional effects in HPV+ HNSCC cells and may promote oncogenesis and tumor maintenance by suppressing the innate immune response and influencing the HPV viral lifecycle. Our group also have a strong interest in translational genomic studies. Our group is working to develop methods that will make gene expression-based biomarkers more successful in the clinic, as well as studying many aspects of genomic alterations that contribute to the development of squamous cell carcinomas. |
Chung, Kay WEBSITE PUBLICATIONS |
PHD PROGRAM RESEARCH INTEREST |
The Chung lab is engineering immune cells, particularly T cells, to achieve maximum therapeutic efficacy at the right place and timing. We explore the crossroads of synthetic biology, immunology, and cancer biology. Particularly, we are employing protein engineering, next-gen sequencing, CRISPR screening, and bioinformatics to achieve our objectives: (1) Combinatorial recipes of transcription factors for T cell programming. (2) Technologies for temporal regulation and/or rewiring of tumor and immune signal activation (chemokine, nuclear, inhibitor receptors). (3) Synthetic oncolytic virus for engineering tumor-T cell crosstalk. |
Ott, Isabel |
PHD PROGRAM RESEARCH INTEREST |
|
Robles, Celeste |
PHD PROGRAM RESEARCH INTEREST |
|
Landis, Justin |
PHD PROGRAM RESEARCH INTEREST |
|
Weight, Abbie |
PHD PROGRAM RESEARCH INTEREST |
|
Bhatt, Urja |
PHD PROGRAM RESEARCH INTEREST |
|
Alam, Ida |
PHD PROGRAM RESEARCH INTEREST |
|
DiMaulo-Milk, Emily |
PHD PROGRAM RESEARCH INTEREST |
|
Khetan, Pri |
PHD PROGRAM RESEARCH INTEREST |
|